© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
November 21, 2019
In a presentation at AHA, T. Jared Bunch, MD, discusses how early detection of AF could yield positive results down the line for patients.
Why US patients are now in absolute need of proven measures to lessen their risk of cardiovascular burden.
A new analysis from Johns Hopkins School of Medicine has found patients in the South, Midwest, and West were all more likely to report poorer healthcare-related quality of life when compared to patients in the Northeast.
What more needs to be learned about the link between the 2 diseases?
The new trial will seek to understand whether atrial fibrillation screening reduces stroke risk.
A conversation with Deepak Bhatt, MD, MPH, discussing the most impactful advances in cardiology in 2019 and what he sees as the most important advances in the past decade as 2019 comes to a close.
November 20, 2019
The study author provides insight into the benefit of inclisiran in at-risk patients with ASCVD.
In a presentation during AHA, Kevin Trulock, MD, explains some of the major risk factors that contribute to atrial fibrillation.
An analysis of 4 phase 3 clinical trials examining the use of bempedoic acid for lowering LDL cholesterol was presented at AHA 2019.
November 19, 2019
How preventive care strategy adherence could bolster heart disease risk reduction in entire families.